UnitedHealth: Why This Healthcare Giant May Keep Sinking For The Rest Of The Year (Archive) Margins and earnings are eroding while bearish price momentum shows no sign of pausing.
UnitedHealth: Margins Are Under Pressure From All Sides (Archive) UnitedHealth faces broad-based, intensifying margin pressures across insurance, provider, and pharmacy businesses.
Pfizer's Q1 Update May Mark A Bottom In The Stock (Archive) Pfizer’s valuation and cost cuts hint at a forming bottom despite structural headwinds.
CVS Health: One Good Quarter Is Not Enough; Retain Sell (Archive) CVS' rally masks persistent insurance margin pressures, rich valuation, and rising leverage risks.
Pfizer: 3 Key Risks That Warrant A Sell (Archive) Patent cliffs, weak margins, and bearish technicals justify maintaining a Sell stance.
Pfizer: Why I'm Staying On The Sidelines (Archive) Staying on the sidelines despite oncology progress and valuation discount.
CVS Health: Insurance Business Challenges Continue (Archive) Margin-crushed benefits segment and bearish charts keep CVS unattractive despite optically cheap valuation.